LAB. CORP.OF AMER. DL-,10
LAB. CORP.OF AMER. DL-,10/ US50540R4092 /
LAB
|
2024-05-13 11:00:25 PM
|
Chg.
+2.00
|
Volume |
Bid11:00:25 PM |
Ask11:00:25 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
193.00EUR
|
+1.05%
|
-
Turnover: - |
193.00Bid Size: - |
197.00Ask Size: - |
16.43 bill.EUR |
- |
- |
Business description
Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
Management board & Supervisory board
| CEO |
| Adam Schechter |
| Management board |
| Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson |
| Supervisory board |
| Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D. |
Company data
| Name: |
Laboratory Corporation of America Holdings |
| Address: |
531 South Spring Street,Burlington, North Carolina 27215, USA |
| Phone: |
+1-336-229-1127 |
| Fax: |
+1-336-436-1569 |
| E-mail: |
-
|
| Internet: |
https://www.labcorp.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
78.40% |
| IPO date: |
- |
Investor relations
| Name: |
Chas Cook |
| IR phone: |
+1-336-436-5076 |
| IR Fax: |
336-436-1569 |
| IR e-mail: |
investor@labcorp.com
|
